• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RABL3 突变改变 KRAS 异戊烯化,与遗传性胰腺癌相关。

Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.

机构信息

Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Nat Genet. 2019 Sep;51(9):1308-1314. doi: 10.1038/s41588-019-0475-y. Epub 2019 Aug 12.

DOI:10.1038/s41588-019-0475-y
PMID:31406347
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7159804/
Abstract

Pancreatic ductal adenocarcinoma is an aggressive cancer with limited treatment options. Approximately 10% of cases exhibit familial predisposition, but causative genes are not known in most families. We perform whole-genome sequence analysis in a family with multiple cases of pancreatic ductal adenocarcinoma and identify a germline truncating mutation in the member of the RAS oncogene family-like 3 (RABL3) gene. Heterozygous rabl3 mutant zebrafish show increased susceptibility to cancer formation. Transcriptomic and mass spectrometry approaches implicate RABL3 in RAS pathway regulation and identify an interaction with RAP1GDS1 (SmgGDS), a chaperone regulating prenylation of RAS GTPases. Indeed, the truncated mutant RABL3 protein accelerates KRAS prenylation and requires RAS proteins to promote cell proliferation. Finally, evidence in patient cohorts with developmental disorders implicates germline RABL3 mutations in RASopathy syndromes. Our studies identify RABL3 mutations as a target for genetic testing in cancer families and uncover a mechanism for dysregulated RAS activity in development and cancer.

摘要

胰腺导管腺癌是一种侵袭性癌症,治疗选择有限。大约 10%的病例表现出家族易感性,但大多数家族中尚未明确致病基因。我们对一个有多例胰腺导管腺癌病例的家族进行了全基因组序列分析,在 RAS 癌基因家族成员 3(RABL3)基因中发现了一个种系截断突变。杂合性 rab13 突变的斑马鱼对癌症形成的敏感性增加。转录组和质谱方法表明 RABL3 参与 RAS 通路调节,并鉴定出与 RAP1GDS1(SmgGDS)的相互作用,SmgGDS 是一种调节 RAS GTP 酶的蛋白前体化的伴侣蛋白。事实上,截短的突变 RABL3 蛋白加速 KRAS 前体化,并需要 RAS 蛋白来促进细胞增殖。最后,在伴有发育障碍的患者队列中的证据表明,胚系 RABL3 突变与 RAS 综合征有关。我们的研究确定 RABL3 突变是癌症家族中进行基因检测的一个靶点,并揭示了发育和癌症中 RAS 活性失调的一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/9d6a01f688de/nihms-1048105-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/0f262431175b/nihms-1048105-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/b7eca91cdf0f/nihms-1048105-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/9dd96cc0e66b/nihms-1048105-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/9d6a01f688de/nihms-1048105-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/0f262431175b/nihms-1048105-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/b7eca91cdf0f/nihms-1048105-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/9dd96cc0e66b/nihms-1048105-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/656f/7159804/9d6a01f688de/nihms-1048105-f0004.jpg

相似文献

1
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.RABL3 突变改变 KRAS 异戊烯化,与遗传性胰腺癌相关。
Nat Genet. 2019 Sep;51(9):1308-1314. doi: 10.1038/s41588-019-0475-y. Epub 2019 Aug 12.
2
Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.对大量胰腺导管腺癌患者的 RABL3 种系序列分析未发现有害变异体的证据。
Genes Chromosomes Cancer. 2021 Aug;60(8):559-564. doi: 10.1002/gcc.22947. Epub 2021 Apr 1.
3
Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.阿托伐他汀抑制 LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre 小鼠的胰腺发生癌变并提高其存活率。
Mol Carcinog. 2013 Sep;52(9):739-50. doi: 10.1002/mc.21916. Epub 2012 Apr 30.
4
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.靶向KRAS用于胰腺癌的诊断、预后评估及治疗:希望与现实
Eur J Cancer. 2016 Feb;54:75-83. doi: 10.1016/j.ejca.2015.11.012. Epub 2015 Dec 28.
5
Low-frequency of RABL3 pathogenetic variants in hereditary and familial pancreatic cancer.遗传性和家族性胰腺癌中RABL3致病变异的低频率
Dig Liver Dis. 2021 Apr;53(4):519-521. doi: 10.1016/j.dld.2020.11.024. Epub 2021 Jan 19.
6
KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas.KRAS 突变等位基因特异性失衡与胰腺癌预后不良和进展为胰腺未分化癌有关。
Mod Pathol. 2013 Oct;26(10):1346-54. doi: 10.1038/modpathol.2013.71. Epub 2013 Apr 19.
7
Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.PTEN 缺失和 Kras 激活协同诱导小鼠胰腺导管细胞形成导管内乳头状黏液性肿瘤。
Gastroenterology. 2018 Apr;154(5):1509-1523.e5. doi: 10.1053/j.gastro.2017.12.007. Epub 2017 Dec 19.
8
Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.转胶蛋白-2 是一种新型 KRAS-ERK 信号靶点,参与胰腺癌的发生发展。
J Exp Clin Cancer Res. 2018 Jul 24;37(1):166. doi: 10.1186/s13046-018-0818-z.
9
SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.SOX9 的活性受致癌性 Kras 的诱导,从而影响胰腺癌中 MDC1 和 MCMs 的表达。
Oncogene. 2018 Feb 15;37(7):912-923. doi: 10.1038/onc.2017.393. Epub 2017 Oct 23.
10
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.激活素受体1B型缺失加速KRAS激活小鼠导管内乳头状黏液性肿瘤的发展。
Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.

引用本文的文献

1
The Development and Toxicological Evaluation of Novel Polyurethane Materials.新型聚氨酯材料的开发与毒理学评价
Toxics. 2025 Jun 18;13(6):512. doi: 10.3390/toxics13060512.
2
Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through Combined Inhibition of FAK and PI3K.通过联合抑制黏着斑激酶(FAK)和磷脂酰肌醇-3-激酶(PI3K)靶向宫颈癌和胰腺癌细胞中的信号兴奋性
Int J Mol Sci. 2025 Mar 26;26(7):3040. doi: 10.3390/ijms26073040.
3
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.用于理解RAS病中神经缺陷的非哺乳动物模型

本文引用的文献

1
Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells.评价新型基因 Rabl3 对人类癌细胞增殖和迁移的调控作用。
Oncol Rep. 2010 Aug;24(2):433-40. doi: 10.3892/or_00000876.
Biomedicines. 2024 Apr 10;12(4):841. doi: 10.3390/biomedicines12040841.
4
Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers.斑马鱼——儿科癌症有效治疗方法快速转化的合适模型。
Cancers (Basel). 2024 Mar 30;16(7):1361. doi: 10.3390/cancers16071361.
5
Prenatal Metal Exposure Alters the Placental Proteome in a Sex-Dependent Manner in Extremely Low Gestational Age Newborns: Links to Gestational Age.产前金属暴露以性别依赖的方式改变极低出生体重儿胎盘蛋白质组:与胎龄的关联。
Int J Mol Sci. 2023 Oct 7;24(19):14977. doi: 10.3390/ijms241914977.
6
An unbiased proteomic analysis of PAD4 in human monocytes: novel substrates, binding partners and subcellular localizations.人单核细胞中 PAD4 的无偏蛋白组学分析:新的底物、结合伙伴和亚细胞定位。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220477. doi: 10.1098/rstb.2022.0477. Epub 2023 Oct 2.
7
Elucidating Structures of Protein Complexes by Collision-Induced Dissociation at Elevated Gas Pressures.在升高的气压下通过碰撞诱导解离阐明蛋白质复合物的结构。
J Am Soc Mass Spectrom. 2023 Oct 4;34(10):2247-2258. doi: 10.1021/jasms.3c00191. Epub 2023 Sep 20.
8
Hereditary cancer syndromes.遗传性癌症综合征
World J Clin Oncol. 2023 Feb 24;14(2):40-68. doi: 10.5306/wjco.v14.i2.40.
9
The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing.小GTP酶转录本复杂、动态的剪接体因技术、性别、遗传学、组织特异性和RNA碱基编辑而改变。
Front Cell Dev Biol. 2022 Nov 17;10:1033695. doi: 10.3389/fcell.2022.1033695. eCollection 2022.
10
MEK1-dependent MondoA phosphorylation regulates glucose uptake in response to ketone bodies in colorectal cancer cells.MEK1 依赖性 MondoA 磷酸化调节结肠直肠癌细胞对酮体的葡萄糖摄取。
Cancer Sci. 2023 Mar;114(3):961-975. doi: 10.1111/cas.15667. Epub 2022 Dec 4.